This Article Full Text Full Text (PDF) All Versions of this Article: 35/2/e39    most recent 01.STR.0000114202.86942.61v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Zee, R. Y.L. Articles by Cook, N. R. Search for Related Content PubMed PubMed Citation Articles by Zee, R. Y.L. Articles by Cook, N. R. Related Collections Genetics of Stroke

(Stroke. 2004;35:e39.)
© 2004 American Heart Association, Inc.

Research Reports

Prospective Evaluation of the Alcohol Dehydrogenase 1/2 Gene Polymorphism and Risk of Stroke

From the Center for Cardiovascular Disease Prevention and the Division of Preventive Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass.

Correspondence to Robert Y.L. Zee, PhD, Brigham & Women’s Hospital, 900 Commonwealth Avenue East, Boston, MA 02215. E-mail rzee{at}rics.bwh.harvard.edu

Background and Purpose— Genetic polymorphism of the alcohol dehydrogenase type 3 gene (ADH1C) has recently been associated with reduced risk of myocardial infarction. However, data on risk of stroke are not available.

Methods— We examined the possible association between the ADH1C 1/2 polymorphism and risk of stroke in a prospective, nested case-control sample from the Physicians’ Health Study of 14 916 apparently healthy men who were followed over a 12-year period. A total of 320 incident stroke cases and 550 age- and smoking-matched controls were genotyped.

Results— All observed genotype frequencies were in Hardy-Weinberg equilibrium. The allele and genotype distributions of the polymorphism tested were similar between cases and controls, such that the relative risk of stroke was 1.04 for ADH1C 1/2 (95% CI=0.85 to 1.28; P=0.65) assuming an additive mode of inheritance. Contrary to prior findings for myocardial infarction, no evidence of association was observed to suggest an effect modification of ADH1C genotypes with the level of alcohol consumption on the risk of stroke. Similar findings were observed in subgroup analysis restricted to ischemic events.

Conclusions— In this large, prospective study, we found little evidence that the ADH1C 1/2 polymorphism is associated with risk of future stroke. These data raise the possibility of important pathologic differences in ischemia between the coronary and cerebral circulations.

Key Words: ADH1C • prospective studies • risk factors • stroke